Moreover, this scenario is further complicated by inflammatory responses to hypomagnesemia even if Mg2+ immunomodulatory function regulates NF-kB activation and cytokine production and limits systemic inflammation, such as C-reactive protein and endothelial dysfunction [101,102]. The gene discussed is NFKB1; the disease is endothelial dysfunction.